Venture Capital

With $12M in new funding, Nadia Care is expanding its community-based model to fight soaring maternal mortality rates in the U.S. and close the care gap.

After four decades as a salon staple, Oligo Professionnel enters the consumer market with its science-led Blacklight Blonde Science line for blondes.

As Cannabix rolls out its THC breathalyzer, a new tool emerges for employers and police. But can it truly distinguish recent use from impairment?

With a new CEO known for successful exits and a breakthrough PFA system for complex arrhythmias, Field Medical is poised to disrupt the cardiac ablation market.

The near-commercial lithium company adds a retired Marine general and a top policy architect to navigate Washington's critical minerals strategy.

As FullPAC sponsors the 2026 Pollie Awards, its focus on AI and a planned public listing reveal a strategy to reshape how elections are won.

San Diego biotech elevates key execs as it advances its inflammation pipeline, backed by Sanofi and Lilly, into a competitive and high-stakes market.

New results from Maxus Mining's Quarry project reveal significant silver, lead, and zinc grades, bolstering BC's role in the critical metals supply chain.

With a unique Nasdaq listing plan and hydrogen-ready tech, Israeli firm Turbogen aims to disrupt the multi-billion dollar U.S. energy market.

As its CFO prepares for key investor meetings at the Roth Conference, Cerence AI aims to prove its dominance in the high-stakes race for the car of the future.

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.

A $2.3B construction firm opens a permanent office, betting its expertise can navigate a biotech real estate market ripe with both opportunity and risk.

With a €1.1M EU grant, Swedish innovator Polar Light is racing to commercialize its unique pyramidal MicroLEDs, aiming to redefine AR and automotive displays.

Inc. names Tiffany Whitlow to its Female Founders 500, validating Acclinate's model of making inclusive clinical research a profitable, high-growth venture.

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

The junior miner's inclusion in the GDXJ and strategic move to Miami aim to boost investor visibility and streamline access to its Colombian gold projects.

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

With a new film, 'One More Christmas,' Candace Cameron Bure solidifies her role as the architect of Great American Media's fast-growing holiday empire.

Red Bull Basement 2026 is open, challenging founders to build startups with AI, offering a $100k prize and a path from idea to the global stage.

With a new $60M fund and a former Lightspeed president, Boreal Ventures aims to turn great Canadian products into global commercial successes.